Science AI Journal
Medicine · Research topic

Open research questions in Esophageal Cancer Research and Treatment

217 unresolved questions extracted from the limitations and future-work sections of 727 Esophageal Cancer Research and Treatment papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The lack of understanding of the genetic factors associated with esophageal carcinogenesis. The need to identify novel candidate genes associated with esophageal squamous cell carcinoma. The requirement for validation of cytogenetically derived genes using tumor genomic architecture.

    Integration of cytogenetic aberrations and in silico pathway enrichment identifies novel candidate genes in esophageal squamous cell carcinoma · 2026 · DOI

  • Future investigations should focus on prospective validation and standardized assay development to determine whether peripheral CIN signatures could serve as non-invasive predictive markers, potentially identifying individuals with heightened genomic vulnerability prior to overt disease manifestation.

    Integration of cytogenetic aberrations and in silico pathway enrichment identifies novel candidate genes in esophageal squamous cell carcinoma · 2026 · DOI

  • The study identifies a gap in the understanding of the impact of surgical approach on postoperative pulmonary function recovery. The study aims to fill this gap by comparing the recovery of respiratory function after esophagectomy using different surgical approaches.

    Comparison of Respiratory function recovery after esophagectomy: a retrospective analysis of surgical approaches · 2026 · DOI

  • The study identifies the challenge of increasing patient complexity over time, with higher proportions of octogenarians, patients with American Society of Anesthesiologists Physical Status ≥ 3, and patients receiving preoperative chemotherapy. The study also identifies the challenge of severe postoperative complications, which remained unchanged over time.

    Improved operative mortality after esophagectomy in patients aged ≥ 75 years over a decade: a nationwide Japanese retrospective cohort study · 2026 · DOI

  • The contribution of MIS to improved operative outcomes in older patients remains unclear. The study aims to fill this gap by evaluating temporal trends in short-term outcomes after esophagectomy in patients aged ≥ 75 years.

    Improved operative mortality after esophagectomy in patients aged ≥ 75 years over a decade: a nationwide Japanese retrospective cohort study · 2026 · DOI

  • Further studies are needed to investigate the effects of other preoperative treatments on nutritional recovery after esophagectomy. Research should focus on developing strategies to improve nutritional outcomes in patients undergoing esophagectomy after induction chemoradiotherapy. Studies should examine the relationship between preoperative treatment and long-term survival outcomes in patients with esophageal cancer. Investigations into the underlying mechanisms of postoperative weight loss and nutritional decline are necessary.

    Long-term nutritional outcomes after esophagectomy following induction chemotherapy versus chemoradiotherapy for T4b esophageal cancer · 2026 · DOI

  • A minor fraction of indolent lesions may have remained undetected during the follow-up period, - The study used a retrospective design, - The operating point of EAGLE can be adjusted by varying the threshold, - Label noise may have been introduced due to undetected indolent lesions, - The study did not investigate the cost-effectiveness of EAGLE

    Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence · 2026 · DOI

  • Investigating the cost-effectiveness of EAGLE, - Evaluating EAGLE's performance in different clinical settings, - Developing methods to reduce label noise, - Exploring the use of EAGLE in other cancer types, - Investigating the potential of EAGLE to detect other diseases

    Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence · 2026 · DOI

  • Non-melanoma skin cancer was excluded from the overall cancer analysis due to incomplete registration and inconsistent recording practices - The study only included participants from the UK Biobank - The study had a limited number of participants for certain cancer types

    Dietary carbohydrate intake and risks of overall and 21 site-specific cancers: a prospective cohort study · 2025 · DOI

  • The impact of preoperative treatment on postoperative nutritional status after esophagectomy for esophageal can- cer has not been fully elucidated.

    Long-term nutritional outcomes after esophagectomy following induction chemotherapy versus chemoradiotherapy for T4b esophageal cancer · 2026 · DOI

  • The relationship between dietary carbohydrate intake and the risk of overall and site-specific cancers is not well understood. There is a lack of comprehensive studies investigating the relationship between dietary carbohydrates and cancer risk. Prior studies have found conflicting evidence on the relationship between dietary carbohydrates and cancer risk.

    Dietary carbohydrate intake and risks of overall and 21 site-specific cancers: a prospective cohort study · 2025 · DOI

  • BACKGROUND Barrett’s esophagus (BE) is a premalignant condition associated with esophageal adenocarcinoma, yet its optimal management remains controversial.

    Impact of surgical vs medical management on histologic outcomes in Barrett’s esophagus: A meta-analysis · 2026 · DOI

  • Guided in-hospital interval training as post-surgical therapy has not been evaluated as a treatment tool.

    In-hospital moderate intensity interval training following surgical resection of foregut malignancy – a prospective single arm feasibility study · 2026 · DOI

  • Clinical utility, including its impact on treatment decision-making and patient outcomes, remains to be demonstrated in future, larger prospective studies.

    CEA-targeted fluorescence endoscopy for the detection of high-grade dysplasia and early invasive rectal cancer: A proof-of-concept trial · 2026 · DOI

  • INTRODUCTION: Gastrointestinal (GI) cancers account for over a quarter of all cancer-related deaths in the United States; however, the latest trends in their prevalence remain unclear.

    Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021 · 2025 · DOI

  • However, relevant applications still face challenges including insufficient data standardization, inadequate interpretability, and weak clinical validation.

    Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: focusing on opportunities and challenges in endoscopy and pathology · 2025 · DOI

  • However, the scale and quality of data across different studies vary widely, and the generalizability of models to multi-center, multi-device environments remains to be verified.

    Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: focusing on opportunities and challenges in endoscopy and pathology · 2025 · DOI

  • Artificial intelligence (AI) has been widely applied in digestive endoscopy; however, AI for pCLE diagnosis of ESN has not been reported.

    Artificial intelligence-aided optical biopsy improves the diagnosis of esophageal squamous neoplasm · 2025 · DOI

  • However, the impact of AI on patients' outcomes such as mortality and interval cancer incidence remains to be seen.

    Role of artificial intelligence in the detection and characterization of gastrointestinal premalignant and early malignant lesions · 2025 · DOI

  • However, the factors and mechanism that drive the malignant progression of BE is not well understood.

    Tetrahydroxylated bile acids prevents malignant progression of Barret esophagus in vitro by inhibiting the interleukin-1β-nuclear factor kappa-B pathway · 2025 · DOI

  • The optimal timing for surgical intervention in patients with tumor progression or metastasis remains controversial; however, the "watch and wait" strategy may represent a viable option for selected individuals.

    Organ preservation in esophageal cancer treatment, is it time now? · 2025 · DOI

  • However, responses to neoadjuvant therapy can vary widely and the key biomarkers to determine response remain poorly understood.

    Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy · 2024 · DOI

  • Despite these advances, the oncological outcomes for advanced esophageal cancer remain controversial due to the frequent observation of local recurrence in the regional or other lymph nodes and distant metastasis after curative treatment.

    Treatment Strategies for Locoregional Recurrence in Esophageal Squamous-Cell Carcinoma: An Updated Review · 2024 · DOI

  • However, the evolution of prognosis over time and the factors affected non-EC deaths remain inadequately studied.

    Conditional survival and annual hazard of death in older patients with esophageal cancer receiving definitive chemoradiotherapy · 2024 · DOI

  • From current evidence, it remains unclear to what extent preoperative chemoradiotherapy (CRT) or preoperative and/or perioperative chemotherapy achieve better outcomes than surgery alone.

    Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction · 2024 · DOI

Most-cited papers in Esophageal Cancer Research and Treatment

Most recent work

Find a gap in your own Esophageal Cancer Research and Treatment sub-topic

This page shows what the Esophageal Cancer Research and Treatment literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,404 open questions
Substance Abuse Treatment and Outcomes
2,046 open questions
Dementia and Cognitive Impairment Research
1,148 open questions
Smoking Behavior and Cessation
1,056 open questions
Innovations in Medical Education
1,015 open questions
Physical Activity and Health
1,010 open questions
Attention Deficit Hyperactivity Disorder
970 open questions
Schizophrenia research and treatment
962 open questions
217 open questions have been extracted from the limitations and future-work passages of 727 Esophageal Cancer Research and Treatment papers in our 4.5M-paper local library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.